Correlation Between Fennec Pharmaceuticals and Akeso,
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and Akeso, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and Akeso, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and Akeso, Inc, you can compare the effects of market volatilities on Fennec Pharmaceuticals and Akeso, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of Akeso,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and Akeso,.
Diversification Opportunities for Fennec Pharmaceuticals and Akeso,
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Fennec and Akeso, is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and Akeso, Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akeso, Inc and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with Akeso,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akeso, Inc has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and Akeso, go up and down completely randomly.
Pair Corralation between Fennec Pharmaceuticals and Akeso,
Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to under-perform the Akeso,. But the stock apears to be less risky and, when comparing its historical volatility, Fennec Pharmaceuticals is 1.46 times less risky than Akeso,. The stock trades about -0.02 of its potential returns per unit of risk. The Akeso, Inc is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 550.00 in Akeso, Inc on August 28, 2024 and sell it today you would earn a total of 330.00 from holding Akeso, Inc or generate 60.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 99.21% |
Values | Daily Returns |
Fennec Pharmaceuticals vs. Akeso, Inc
Performance |
Timeline |
Fennec Pharmaceuticals |
Akeso, Inc |
Fennec Pharmaceuticals and Akeso, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fennec Pharmaceuticals and Akeso,
The main advantage of trading using opposite Fennec Pharmaceuticals and Akeso, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, Akeso, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akeso, will offset losses from the drop in Akeso,'s long position.Fennec Pharmaceuticals vs. Eliem Therapeutics | Fennec Pharmaceuticals vs. Scpharmaceuticals | Fennec Pharmaceuticals vs. Milestone Pharmaceuticals | Fennec Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
CEOs Directory Screen CEOs from public companies around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |